Bahl & Gaynor Inc West Pharmaceutical Services Inc Transaction History

Bahl & Gaynor Inc

$19.3 Billion
Q3 2024

A detailed history of Bahl & Gaynor Inc transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Bahl & Gaynor Inc holds 4,767 shares of WST stock, worth $1.59 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,767

Previous 4,327 10.17%

Holding current value

$1.59 Million

Previous $1.43 Million 0.35%

% of portfolio

0.01%

Previous 0.01%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$277.16 - $333.3 $121,950 - $146,652	440 Added 10.17%	4,767 $1.43 Million
Q2 2024 Aug 07, 2024	SELL	$314.68 - $395.94 $204,227 - $256,965	-649 Reduced 13.04%	4,327 $1.43 Million
Q1 2024 May 10, 2024	BUY	$338.27 - $413.0 $693,453 - $846,650	2,050 Added 70.06%	4,976 $1.97 Million
Q4 2023 Feb 02, 2024	SELL	$318.29 - $392.21 $68,114 - $83,932	-214 Reduced 6.82%	2,926 $1.03 Million
Q3 2023 Nov 03, 2023	BUY	$354.9 - $412.41 $117,116 - $136,095	330 Added 11.74%	3,140 $1.18 Million
Q2 2023 Aug 14, 2023	SELL	$334.63 - $382.47 $79,307 - $90,645	-237 Reduced 7.78%	2,810 $1.07 Million
Q1 2023 May 03, 2023	SELL	$232.5 - $346.47 $15,112 - $22,520	-65 Reduced 2.09%	3,047 $1.06 Million
Q4 2022 Feb 10, 2023	SELL	$209.34 - $261.61 $62,173 - $77,698	-297 Reduced 8.71%	3,112 $732,000
Q3 2022 Nov 14, 2022	SELL	$246.08 - $343.65 $192,680 - $269,077	-783 Reduced 18.68%	3,409 $839,000
Q2 2022 Aug 08, 2022	BUY	$280.61 - $420.45 $220,559 - $330,473	786 Added 23.08%	4,192 $1.27 Million
Q1 2022 May 12, 2022	SELL	$357.49 - $445.92 $124,764 - $155,626	-349 Reduced 9.29%	3,406 $1.4 Million
Q4 2021 Feb 10, 2022	SELL	$402.25 - $471.34 $1.26 Million - $1.48 Million	-3,142 Reduced 45.56%	3,755 $1.76 Million
Q3 2021 Nov 15, 2021	SELL	$363.01 - $468.47 $10,890 - $14,054	-30 Reduced 0.43%	6,897 $2.93 Million
Q2 2021 Aug 06, 2021	SELL	$284.77 - $363.2 $576,374 - $735,116	-2,024 Reduced 22.61%	6,927 $2.49 Million
Q1 2021 May 11, 2021	SELL	$257.29 - $307.53 $1.57 Million - $1.88 Million	-6,107 Reduced 40.56%	8,951 $2.52 Million
Q4 2020 Feb 02, 2021	BUY	$261.16 - $301.66 $106,030 - $122,473	406 Added 2.77%	15,058 $4.27 Million
Q3 2020 Nov 12, 2020	SELL	$224.99 - $288.02 $60,297 - $77,189	-268 Reduced 1.8%	14,652 $4.03 Million
Q2 2020 Aug 13, 2020	SELL	$149.8 - $227.17 $333,005 - $504,998	-2,223 Reduced 12.97%	14,920 $3.39 Million
Q1 2020 May 26, 2020	BUY	$128.96 - $174.76 $2.21 Million - $3 Million	17,143 New	17,143 $2.61 Million
Q1 2020 May 15, 2020	SELL	$128.96 - $174.76 $2.29 Million - $3.1 Million	-17,758 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$137.6 - $151.21 $114,483 - $125,806	-832 Reduced 4.48%	17,758 $2.67 Million
Q3 2019 Nov 14, 2019	SELL	$121.41 - $150.02 $34,480 - $42,605	-284 Reduced 1.5%	18,590 $2.64 Million
Q1 2019 May 13, 2019	BUY	$94.53 - $110.2 $23,632 - $27,550	250 Added 1.34%	18,874 $2.08 Million
Q4 2018 Feb 12, 2019	SELL	$93.0 - $123.98 $59,520 - $79,347	-640 Reduced 3.32%	18,624 $1.83 Million
Q3 2018 Nov 09, 2018	SELL	$98.01 - $123.47 $588 - $740	-6 Reduced 0.03%	19,264 $2.38 Million
Q2 2018 Aug 14, 2018	SELL	$83.32 - $101.88 $4,415 - $5,399	-53 Reduced 0.27%	19,270 $1.91 Million
Q1 2018 May 11, 2018	SELL	$85.56 - $102.4 $3,422 - $4,096	-40 Reduced 0.21%	19,323 $1.71 Million
Q4 2017 Feb 13, 2018	SELL	$91.65 - $101.65 $190,173 - $210,923	-2,075 Reduced 9.68%	19,363 $1.91 Million
Q3 2017 Nov 13, 2017	SELL	$84.54 - $96.75 $71,859 - $82,237	-850 Reduced 3.81%	21,438 $2.06 Million
Q2 2017 Aug 11, 2017	SELL	N/A	-23,846 Reduced 51.69%	22,288 $2.11 Million
Q2 2017 Aug 10, 2017	BUY	N/A	46,134	46,134 $3.91 Million

Others Institutions Holding WST

# of Institutions

803

Shares Held

64.4M

Call Options Held

294K

Put Options Held

490K

View Full List

About WEST PHARMACEUTICAL SERVICES INC

Ticker WST
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,033,000
Market Cap $24.7B
Description
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...

More about WST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bahl & Gaynor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bahl & Gaynor Inc with notifications on news.

Account